CoChat

Network-driven plasma proteomics expose molecular changes in the Alzheimer’s brain

Open access
Jaeger, Philipp A., Lucin, Kurt M., Britschgi, Markus, Vardarajan, Badri, Huang, Ruo-Pan, Kirby, Elizabeth D., Abbey, Rachelle, Boeve, Bradley F., Boxer, Adam L., Farrer, Lindsay A., Finch, NiCole, Graff-Radford, Neill R., Head, Elizabeth, Hofree, Matan, Huang, Ruochun, Johns, Hudson, Karydas, Anna, Knopman, David S., Loboda, Andrey, Masliah, Eliezer, Narasimhan, Ramya, Petersen, Ronald C., Podtelezhnikov, Alexei, Pradhan, Suraj, Rademakers, Rosa, Sun, Chung-Huan, Younkin, Steven G., Miller, Bruce L., Ideker, Trey, Wyss-Coray, Tony · 2016 · Molecular Neurodegeneration
Cited by 35

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Biological pathways that significantly contribute to sporadic Alzheimer's disease are largely unknown and cannot be observed directly. Cognitive symptoms appear only decades after the molecular disease onset, further complicating analyses. As a consequence, molecular research is often restricted to late-stage post-mortem studies of brain tissue. However, the disease process is expected to trigger numerous cellular signaling pathways and modulate the local and systemic environment, and resulting changes in secreted signaling molecules carry information about otherwise inaccessible pathological processes. RESULTS: To access this information we probed relative levels of close to 600 secreted signaling proteins from patients' blood samples using antibody microarrays and mapped disease-specific molecular networks. Using these networks as seeds we then employed independent genome and transcriptome data sets to corroborate potential pathogenic pathways. CONCLUSIONS: We identified Growth-Differentiation Factor (GDF) signaling as a novel Alzheimer's disease-relevant pathway supported by in vivo and in vitro follow-up experiments, demonstrating the existence of a highly informative link between cellular pathology and changes in circulatory signaling proteins.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13024-016-0095-2

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 35

Metadata

Authors
Jaeger, P. A., Lucin, K. M., Britschgi, M., Vardarajan, B., Huang, R.-P., Kirby, E. D., Abbey, R., Boeve, B. F., Boxer, A. L., Farrer, L. A., Finch, N., Graff-Radford, N. R., Head, E., Hofree, M., Huang, R., Johns, H., Karydas, A., Knopman, D. S., Loboda, A., Masliah, E., Narasimhan, R., Petersen, R. C., Podtelezhnikov, A., Pradhan, S., Rademakers, R., Sun, C.-H., Younkin, S. G., Miller, B. L., Ideker, T., & Wyss-Coray, T.
Venue
Molecular Neurodegeneration
Published
2016-04-26
Volume
11
Issue
1
Pages
31-31
ISSN
1750-1326 (ISSN-L)
OpenAlex
W2343713183
Cited by
35
References
20
FWCI
4.33
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Network-driven plasma proteomics expose molecular changes in the Alzheimer’s brain. https://app.cochat.ai/papers/10.1186/s13024-016-0095-2
The paper
Jaeger, P. A., Lucin, K. M., Britschgi, M., Vardarajan, B., Huang, R.-P., Kirby, E. D., Abbey, R., Boeve, B. F., Boxer, A. L., Farrer, L. A., Finch, N., Graff-Radford, N. R., Head, E., Hofree, M., Huang, R., Johns, H., Karydas, A., Knopman, D. S., Loboda, A., . . . Wyss-Coray, T. (2016). Network-driven plasma proteomics expose molecular changes in the Alzheimer’s brain. Molecular Neurodegeneration. https://doi.org/10.1186/s13024-016-0095-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.